Drug Shortage Report for ERYTHROCIN I.V.

Last updated on 2022-09-27 History
Report ID 169767
Drug Identification Number 00682268
Brand name ERYTHROCIN I.V.
Common or Proper name Erythromycin Lactobionate for Injection
Company Name AMDIPHARM LIMITED
Market Status MARKETED
Active Ingredient(s) ERYTHROMYCIN
Strength(s) 500MG
Dosage form(s) POWDER FOR SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS
Packaging size 10 vials
ATC code J01FA
ATC description MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS
Reason for shortage Other (Please describe in comments)
Anticipated start date 2022-09-23
Actual start date
Estimated end date Unknown
Actual end date 2022-09-26
Shortage status Resolved
Updated date 2022-09-27
Company comments Delay in release. As of Sept 26 2022, release resolved.
Health Canada comments
Tier 3 Status No
Contact Address 3 BURLINGTON ROAD
DUBLIN, LEINSTER
IRELAND DUBLIN 4
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v11 2022-09-27 English Compare
v10 2022-09-26 French Compare
v9 2022-09-26 French Compare
v8 2022-09-26 French Compare
v7 2022-09-26 English Compare
v6 2022-09-24 English Compare
v5 2022-09-22 French Compare
v4 2022-09-22 English Compare
v3 2022-09-22 French Compare
v2 2022-09-22 English Compare
v1 2022-09-22 English Compare

Showing 1 to 11 of 11